Lighthouse
DENVER, CO / ACCESSWIRE / February 29, 2024 / Lighthouse, the leading commercial platform for the travel & hospitality industry, today announced the launch of Smart Summaries within its award-winning Business Intelligence solution. Smart Summaries leverage generative AI to transform complex data sets into easy-to-read daily performance summaries for hotel commercial teams, transforming how hotels interpret complex data to make revenue decisions.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Generative artificial intelligence (GenAI) is helping hotels tackle tasks like writing marketing copy and automating responses to guest inquiries with chat bots. But turning quantitative data into actionable insights has remained elusive. Now, Lighthouse is using the latest advancements in GenAI to dramatically improve the quality and speed of quantitative data analysis for Revenue Managers.
In an industry first, Lighthouse is leveraging advanced GenAI learning models to provide hotel professionals with customized daily performance summaries directly to their inbox. This advanced technology was built and rigorously trained using vast data sets and tens of thousands of human-written performance summaries as part of the training models. Smart Summaries are able to capture and summarize changes in pick-up, ADR, segmentation, and occupancy that previously took hours to compile.
"With the introduction of Smart Summaries, Lighthouse is at the forefront of generative AI innovation for hospitality businesses," said Sean Fitzpatrick, CEO of Lighthouse. "Our goal is to take revenue management to the next level, eliminating the more mundane administrative tasks, and freeing up time to make great commercial decisions and grow revenue.
We're just getting started with generative AI. It complements our other advanced AI and machine learning capabilities perfectly and we envision our platform becoming an even more invaluable commercial co-pilot over time."
To build the GenAI capabilities, Lighthouse worked with thousands of hotels to identify the number one time-consuming task for revenue managers: managing repetitive daily performance communications with stakeholders. Smart Summaries directly address this challenge by automating the generation of insightful, easy-to-understand performance summaries, freeing up time for more strategic initiatives.
Key benefits of Smart Summaries include:
- Reduction of non-revenue generating workload so hoteliers can focus on strategic initiatives that drive revenue
- Timely identification of actionable insights that impact pricing and promotional strategies
- Improved efficiency for hospitality commercial teams
Lighthouse's Smart Summaries leverage generative AI to transform how revenue managers use data. Greg Peppel, Head of BI Products at Lighthouse said, "Research by HSMAI indicates that revenue managers spend over half their time on tasks that don't generate revenue. Our goal is to shift this dynamic, enabling them to focus on strategic activities by utilizing AI to save time and streamline the complexity of data analysis."
Smart Summaries are currently available to a limited set of Lighthouse BI customers and will be rolled out globally over the coming months.
About Lighthouse
Lighthouse (formerly OTA Insight) is the leading commercial platform for the travel & hospitality industry. We transform complexity into confidence by providing actionable market insights, business intelligence, and pricing tools that maximize revenue growth. We continually innovate to deliver the best platform for hospitality professionals to price more effectively, measure performance more efficiently, and understand the market in new ways.
Trusted by over 65,000 hotels in 185 countries, Lighthouse is the only solution that provides real-time hotel and short-term rental data in a single platform. We strive to deliver the best possible experience with unmatched customer service. We consider our clients as true partners - their success is our success.
Contact: Adam Swart
Email: adam.swart@mylighthouse.com | Phone:+44 203 095 2727
SOURCE: Lighthouse
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Karbon-X Advances Community-Led Forest Protection in Colombia's Meta Region19.11.2025 15:00:00 CET | Press release
New phase of the Sur del Meta Project expands carbon and biodiversity monitoring while strengthening local governance and livelihoods. CALGARY, AB / ACCESS Newswire / November 19, 2025 / In the heart of Colombia's Meta department, where forests and farmlands converge, Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company") is deepening its commitment to people-powered climate solutions through the REDD+ Sur del Meta Project - a long-term conservation initiative that protects 40,637 hectares of natural forest while supporting sustainable livelihoods for nearly 1,000 local families. Developed through ALLCOT - A Karbon-X Company, the project development and advisory arm of Karbon-X, the initiative operates across the municipalities of Vistahermosa, Puerto Rico, Puerto Concordia, and Puerto Lleras, a region historically affected by deforestation and armed conflict. The project partners with local farmers, many of whom are victims of Colombia's armed conflict, helping them transition from
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom